How does long-term use of Bromocriptine affect bone density and overall skeletal health, particularly in older patients or those at risk for osteoporosis?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Bromocriptine, a dopamine agonist, may decrease bone density over prolonged use, raising osteoporosis risk in older patients or those predisposed.
Long-term use of bromocriptine may increase the risk of osteoporosis by lowering estrogen levels, affecting bone density, especially in older patients.